Report Detail
Global Felodipine Sustained-Release Tablet Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4511770 |
- 16 February, 2023 |
- Global |
- 93 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Felodipine sustained-release tablets are used to treat hypertension and stable angina pectoris.
According to our (Global Info Research) latest study, the global Felodipine Sustained-Release Tablet market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Felodipine Sustained-Release Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Felodipine Sustained-Release Tablet market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Felodipine Sustained-Release Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Felodipine Sustained-Release Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Felodipine Sustained-Release Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Felodipine Sustained-Release Tablet
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Felodipine Sustained-Release Tablet market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon and Changzhou Siyao Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Felodipine Sustained-Release Tablet market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2.5mg Per Tablet
5mg Per Tablet
Others
Market segment by Application
Treat High Blood Pressure
Relieve Angina
Others
Major players covered
Astrazeneca
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
Lifeon
Changzhou Siyao Pharmaceutical
Mylan
Sandoz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Felodipine Sustained-Release Tablet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Felodipine Sustained-Release Tablet, with price, sales, revenue and global market share of Felodipine Sustained-Release Tablet from 2018 to 2023.
Chapter 3, the Felodipine Sustained-Release Tablet competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Felodipine Sustained-Release Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Felodipine Sustained-Release Tablet market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Felodipine Sustained-Release Tablet.
Chapter 14 and 15, to describe Felodipine Sustained-Release Tablet sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Felodipine Sustained-Release Tablet
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Felodipine Sustained-Release Tablet Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 2.5mg Per Tablet
- 1.3.3 5mg Per Tablet
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Felodipine Sustained-Release Tablet Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Treat High Blood Pressure
- 1.4.3 Relieve Angina
- 1.4.4 Others
- 1.5 Global Felodipine Sustained-Release Tablet Market Size & Forecast
- 1.5.1 Global Felodipine Sustained-Release Tablet Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Felodipine Sustained-Release Tablet Sales Quantity (2018-2029)
- 1.5.3 Global Felodipine Sustained-Release Tablet Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Astrazeneca
- 2.1.1 Astrazeneca Details
- 2.1.2 Astrazeneca Major Business
- 2.1.3 Astrazeneca Felodipine Sustained-Release Tablet Product and Services
- 2.1.4 Astrazeneca Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Astrazeneca Recent Developments/Updates
- 2.2 NanJing Easeheal Phaemaecutical
- 2.2.1 NanJing Easeheal Phaemaecutical Details
- 2.2.2 NanJing Easeheal Phaemaecutical Major Business
- 2.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product and Services
- 2.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 NanJing Easeheal Phaemaecutical Recent Developments/Updates
- 2.3 SHANXI KANGBO BIOLOGICAL PRODUCT
- 2.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Details
- 2.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Major Business
- 2.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product and Services
- 2.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
- 2.4 Lifeon
- 2.4.1 Lifeon Details
- 2.4.2 Lifeon Major Business
- 2.4.3 Lifeon Felodipine Sustained-Release Tablet Product and Services
- 2.4.4 Lifeon Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Lifeon Recent Developments/Updates
- 2.5 Changzhou Siyao Pharmaceutical
- 2.5.1 Changzhou Siyao Pharmaceutical Details
- 2.5.2 Changzhou Siyao Pharmaceutical Major Business
- 2.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product and Services
- 2.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
- 2.6 Mylan
- 2.6.1 Mylan Details
- 2.6.2 Mylan Major Business
- 2.6.3 Mylan Felodipine Sustained-Release Tablet Product and Services
- 2.6.4 Mylan Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Mylan Recent Developments/Updates
- 2.7 Sandoz
- 2.7.1 Sandoz Details
- 2.7.2 Sandoz Major Business
- 2.7.3 Sandoz Felodipine Sustained-Release Tablet Product and Services
- 2.7.4 Sandoz Felodipine Sustained-Release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Sandoz Recent Developments/Updates
3 Competitive Environment: Felodipine Sustained-Release Tablet by Manufacturer
- 3.1 Global Felodipine Sustained-Release Tablet Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Felodipine Sustained-Release Tablet Revenue by Manufacturer (2018-2023)
- 3.3 Global Felodipine Sustained-Release Tablet Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Felodipine Sustained-Release Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Felodipine Sustained-Release Tablet Manufacturer Market Share in 2022
- 3.4.2 Top 6 Felodipine Sustained-Release Tablet Manufacturer Market Share in 2022
- 3.5 Felodipine Sustained-Release Tablet Market: Overall Company Footprint Analysis
- 3.5.1 Felodipine Sustained-Release Tablet Market: Region Footprint
- 3.5.2 Felodipine Sustained-Release Tablet Market: Company Product Type Footprint
- 3.5.3 Felodipine Sustained-Release Tablet Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Felodipine Sustained-Release Tablet Market Size by Region
- 4.1.1 Global Felodipine Sustained-Release Tablet Sales Quantity by Region (2018-2029)
- 4.1.2 Global Felodipine Sustained-Release Tablet Consumption Value by Region (2018-2029)
- 4.1.3 Global Felodipine Sustained-Release Tablet Average Price by Region (2018-2029)
- 4.2 North America Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
- 4.3 Europe Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
- 4.4 Asia-Pacific Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
- 4.5 South America Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
- 4.6 Middle East and Africa Felodipine Sustained-Release Tablet Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
- 5.2 Global Felodipine Sustained-Release Tablet Consumption Value by Type (2018-2029)
- 5.3 Global Felodipine Sustained-Release Tablet Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
- 6.2 Global Felodipine Sustained-Release Tablet Consumption Value by Application (2018-2029)
- 6.3 Global Felodipine Sustained-Release Tablet Average Price by Application (2018-2029)
7 North America
- 7.1 North America Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
- 7.2 North America Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
- 7.3 North America Felodipine Sustained-Release Tablet Market Size by Country
- 7.3.1 North America Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2029)
- 7.3.2 North America Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
- 8.2 Europe Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
- 8.3 Europe Felodipine Sustained-Release Tablet Market Size by Country
- 8.3.1 Europe Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Felodipine Sustained-Release Tablet Market Size by Region
- 9.3.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Felodipine Sustained-Release Tablet Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
- 10.2 South America Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
- 10.3 South America Felodipine Sustained-Release Tablet Market Size by Country
- 10.3.1 South America Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2029)
- 10.3.2 South America Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Felodipine Sustained-Release Tablet Market Size by Country
- 11.3.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Felodipine Sustained-Release Tablet Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Felodipine Sustained-Release Tablet Market Drivers
- 12.2 Felodipine Sustained-Release Tablet Market Restraints
- 12.3 Felodipine Sustained-Release Tablet Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Felodipine Sustained-Release Tablet and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Felodipine Sustained-Release Tablet
- 13.3 Felodipine Sustained-Release Tablet Production Process
- 13.4 Felodipine Sustained-Release Tablet Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Felodipine Sustained-Release Tablet Typical Distributors
- 14.3 Felodipine Sustained-Release Tablet Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Felodipine Sustained-Release Tablet. Industry analysis & Market Report on Felodipine Sustained-Release Tablet is a syndicated market report, published as Global Felodipine Sustained-Release Tablet Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Felodipine Sustained-Release Tablet market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
